Targeting of stabilin-1 may therefore allow modulation of the hepatic Treg pool or prevention of tumour metastasis; indeed, genetic deficiency or antibody blockade of stabilin-1 reduces immunosuppressive leukocytes within tumours and halts tumour progression in mice (Karikoski et al., 2014). The gene discussed is STAB1; the disease is neoplasm.